GSK's kidney disease anaemia drug approved in Japan, taking ...

GlaxoSmithKline’s drug for anaemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas. 

Seattle Genetics says data backs Padcev combo for first-line...

Xtandi takes fight to prostate cancer rivals with survival d...

Astellas to work with Adaptimmune to develop 'off the shelf'...

Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer.

FDA backs Astellas/Seattle Genetics bladder cancer drug

The FDA has quickly okayed Astellas and Seattle Genetics’ advanced bladder cancer drug enfortumab vedotin, one of the stars of this year’s ASCO conference that was considered an almost dead

Xtandi catches up with Erleada in castration-sensitive prost...